Worcester biopharma faces delisting from Nasdaq

Retrieved on: 2024-09-18 15:26:33

Tags for this article:

Stock market

Mustang Bio

NASDAQ

Listing

Click the tags to see associated articles and topics

Worcester biopharma faces delisting from Nasdaq. View article details on hiswai:

Summary

The article discusses Mustang Bio’s struggle with maintaining compliance with Nasdaq’s stockholders' equity requirement, risking delisting. Relating to 'capital markets', it highlights the challenges companies face to stay listed. Tags like 'Stock market' and 'NASDAQ' are directly relevant.

Article found on: www.wbjournal.com

View Original Article